• Contact IR
  • FAQS
  • Corporate Website
BioStem Technologies, Inc
Investor relations
  • Overview
  • News
  • Events & Presentations
    • Events
    • Latest Presentation
  • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Stock Info
  • Resources
    • Board of Directors
    • Management Team
    • Scientific Advisory Board
    • Analysts
    • Investor Email Alerts
  • Corporate Website
Select Page
  • Overview
  • News
  • Events & Presentations
    • Events
    • Latest Presentation
  • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Stock Info
  • Resources
    • Board of Directors
    • Management Team
    • Scientific Advisory Board
    • Analysts
    • Investor Email Alerts
  • Corporate Website
  • Contact IR
  • FAQS
  • Corporate Website

Latest News

Investor Relations

Latest News

Select Year:
May 12, 2025 04:00 pm

BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results

May 1, 2025 07:00 am

BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting

April 30, 2025 07:00 am

BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025

April 21, 2025 07:07 am

BioStem Technologies to Present at the Centri Capital Conference

April 14, 2025 04:14 pm

BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million

April 8, 2025 07:00 am

BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025

April 1, 2025 04:49 pm

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

March 31, 2025 07:00 am

BioStem Announces Notice of Allowance for Two U.S. Patent Applications

March 27, 2025 07:00 am

BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare Conference

February 24, 2025 07:00 am

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology in Treating Venous Leg Ulcers

1 2 3 … 9 Next »
  • Home
  • Our Science
  • Products
  • Resources
  • About Us
  • Contact Us
  • FAQS
  • CAREERS
  • TERMS AND CONDITIONS
  • PRIVACY POLICY
  • SHIPPING POLICY
  • REFUND POLICY
  • COOKIE POLICY
  • RSS
  • Instagram
  • X

© 2025 BioStem Technologies, Inc. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.

For screen reader problems with this website, please call (954) 380-8342 for assistance.

Disclaimer

You are about to review presentations, reports and/or filings of BioStem Technologies, Inc., that contain time-sensitive information. The information contained therein is only accurate as of the date thereof. BioStem Technologies, Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by BioStem Technologies, Inc.

I Accept I Decline